Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis have?
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis has 427 citations in the OpenAlex counts ScholarIQ stores.
When was Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis published?
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis has 2017 year in the ScholarIQ index.
What is the open-access status of Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis?
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis has bronze oa status in the ScholarIQ index.
What is the DOI of Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis?
The DOI for Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis is on the source record.
What is the PMID of Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis?
The PMID for Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis is on the source record.
What is the OpenAlex record for Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis?
The OpenAlex for Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis is on the source record.